AU2010283583A1 - Treatment of viral infections - Google Patents

Treatment of viral infections Download PDF

Info

Publication number
AU2010283583A1
AU2010283583A1 AU2010283583A AU2010283583A AU2010283583A1 AU 2010283583 A1 AU2010283583 A1 AU 2010283583A1 AU 2010283583 A AU2010283583 A AU 2010283583A AU 2010283583 A AU2010283583 A AU 2010283583A AU 2010283583 A1 AU2010283583 A1 AU 2010283583A1
Authority
AU
Australia
Prior art keywords
amino
compound
propan
chlorophenyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2010283583A
Other languages
English (en)
Inventor
Robin Mark Bannister
John Brew
Olga Pleguezuelos Mateo
Gregory Alan Stoloff
Wilson Capparros Wanderlay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocopea Ltd
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0913914A external-priority patent/GB0913914D0/en
Priority claimed from GBGB1001821.6A external-priority patent/GB201001821D0/en
Priority claimed from GB1012168A external-priority patent/GB2477584A/en
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of AU2010283583A1 publication Critical patent/AU2010283583A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2010283583A 2009-08-10 2010-08-10 Treatment of viral infections Abandoned AU2010283583A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0913914A GB0913914D0 (en) 2009-08-10 2009-08-10 Treatment of viral infections
GB0913914.8 2009-08-10
GBGB1001821.6A GB201001821D0 (en) 2010-02-04 2010-02-04 Treatment of viral infections
GB1001821.6 2010-02-04
GB1012168A GB2477584A (en) 2010-02-04 2010-07-20 A compound for use in treating an acute viral infection
GB1012168.9 2010-07-20
PCT/GB2010/051317 WO2011018653A2 (en) 2009-08-10 2010-08-10 Treatment of viral infections

Publications (1)

Publication Number Publication Date
AU2010283583A1 true AU2010283583A1 (en) 2012-03-08

Family

ID=43063293

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010283583A Abandoned AU2010283583A1 (en) 2009-08-10 2010-08-10 Treatment of viral infections

Country Status (9)

Country Link
US (1) US20120283334A1 (https=)
EP (1) EP2464345A2 (https=)
JP (1) JP2013501770A (https=)
CN (1) CN102497860A (https=)
AU (1) AU2010283583A1 (https=)
IN (1) IN2012DN02123A (https=)
RU (1) RU2012108048A (https=)
SG (1) SG178345A1 (https=)
WO (1) WO2011018653A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108721262A (zh) * 2017-04-13 2018-11-02 中国科学院武汉病毒研究所 安非他酮在制备治疗或预防流感病毒感染的药物中的应用
CN115068453A (zh) * 2021-03-15 2022-09-20 中国医学科学院药物研究所 沙美特罗防治流感的药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4166955B2 (ja) * 1998-12-08 2008-10-15 プラニスフィア コーポレイション ウイルス疾患を処置するためのビュープロピオン
US20060173080A1 (en) * 2002-09-14 2006-08-03 The Regents Of The University Of California Methods of modulating TNF using bupropion
DE102004063132A1 (de) * 2004-12-22 2006-07-06 Schmiegel, Wolff, Prof. Dr. Verwendung von Bupropion in Arzneimittel zur Behandlung von Hepatitis C

Also Published As

Publication number Publication date
JP2013501770A (ja) 2013-01-17
IN2012DN02123A (https=) 2015-08-21
WO2011018653A2 (en) 2011-02-17
US20120283334A1 (en) 2012-11-08
WO2011018653A3 (en) 2011-04-07
EP2464345A2 (en) 2012-06-20
RU2012108048A (ru) 2013-09-20
SG178345A1 (en) 2012-03-29
CN102497860A (zh) 2012-06-13

Similar Documents

Publication Publication Date Title
US12370206B2 (en) Therapy for inhibition of single-stranded RNA virus replication
JP6294889B2 (ja) ウイルス疾患の処置におけるｍｅｋ阻害物質
US11612574B2 (en) Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
EA037529B1 (ru) Способ получения соединения для ингибирования репликации вирусов гриппа
CN103648491B (zh) 用于抑制流感病毒复制的方法和药物组合物
KR20180074654A (ko) 바이러스 감염의 치료를 위한 조성물 및 방법
WO2021248008A1 (en) Arylamide compounds for treatment and prevention of viral infections
CN114667138A (zh) Mek抑制剂与帽状结构依赖型核酸内切酶抑制剂的组合
AU2010283583A1 (en) Treatment of viral infections
CA2780614A1 (en) Treatment of microbial infections
JP2011522039A (ja) ウイルス抑制剤として有用なジアリールヘパトノイド系化合物
GB2477584A (en) A compound for use in treating an acute viral infection
KR100930480B1 (ko) 신규 디아릴 헵타노이드계 화합물 및 그 용도
WO2026044019A1 (en) Compositions and methods for treating influenza infection
EP2844251B1 (en) Compositions and methods for increasing neurotrophic peptides
KR100931249B1 (ko) 신규 디아릴 헵타노이드계 화합물 및 그 용도

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application